Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H1N1 and Seasonal Flu Vaccine Co-administration Study
NCT00943878Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2009
- Primary completion
- Apr 2010
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Influenza A (H1N1) vaccine in influenza A/H1N1 (H1N1) (4 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Number of Participants With a Serum Hemagglutination Inhibition Assay (HAI) Antibody Titer of 1:40 or Greater Against the H1N1 2009 Virus at Day 21, Number of Participants Reporting Vaccine-associated Serious Adverse Events (SAEs) at Day 180 and 4 more. Started Aug 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
influenza A/H1N1 (H1N1)
Beyond the preview
Go deeper on NCT00943878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00943878.